Minerva Neurosciences (NERV) Misses Q4 EPS by 153c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($0.56), $1.53 worse than the analyst estimate of $0.97.

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Oppenheimer Downgrades AtaiBeckley Inc (ATAI) to Perform
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'